379 related articles for article (PubMed ID: 31432449)
21. A conditional pan-neuronal Drosophila model of spinocerebellar ataxia 7 with a reversible adult phenotype suitable for identifying modifier genes.
Latouche M; Lasbleiz C; Martin E; Monnier V; Debeir T; Mouatt-Prigent A; Muriel MP; Morel L; Ruberg M; Brice A; Stevanin G; Tricoire H
J Neurosci; 2007 Mar; 27(10):2483-92. PubMed ID: 17344386
[TBL] [Abstract][Full Text] [Related]
22. Polyglutamine-expanded ATXN7 alters a specific epigenetic signature underlying photoreceptor identity gene expression in SCA7 mouse retinopathy.
Niewiadomska-Cimicka A; Hache A; Le Gras S; Keime C; Ye T; Eisenmann A; Harichane I; Roux MJ; Messaddeq N; Clérin E; Léveillard T; Trottier Y
J Biomed Sci; 2022 Dec; 29(1):107. PubMed ID: 36539812
[TBL] [Abstract][Full Text] [Related]
23. Poly(Q) Expansions in ATXN7 Affect Solubility but Not Activity of the SAGA Deubiquitinating Module.
Lan X; Koutelou E; Schibler AC; Chen YC; Grant PA; Dent SY
Mol Cell Biol; 2015 May; 35(10):1777-87. PubMed ID: 25755283
[TBL] [Abstract][Full Text] [Related]
24. Spinocerebellar ataxia 7 (SCA7).
Lebre AS; Brice A
Cytogenet Genome Res; 2003; 100(1-4):154-63. PubMed ID: 14526176
[TBL] [Abstract][Full Text] [Related]
25. The Molecular Basis of Spinocerebellar Ataxia Type 7.
Goswami R; Bello AI; Bean J; Costanzo KM; Omer B; Cornelio-Parra D; Odah R; Ahluwalia A; Allan SK; Nguyen N; Shores T; Aziz NA; Mohan RD
Front Neurosci; 2022; 16():818757. PubMed ID: 35401096
[TBL] [Abstract][Full Text] [Related]
26. Progressive degeneration in a new
Sujkowski AL; Ranxhi B; Prifti MV; Alam N; Todi SV; Tsou WL
Res Sq; 2023 Nov; ():. PubMed ID: 38045332
[TBL] [Abstract][Full Text] [Related]
27. Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3.
Zander C; Takahashi J; El Hachimi KH; Fujigasaki H; Albanese V; Lebre AS; Stevanin G; Duyckaerts C; Brice A
Hum Mol Genet; 2001 Oct; 10(22):2569-79. PubMed ID: 11709544
[TBL] [Abstract][Full Text] [Related]
28. Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7.
Furrer SA; Waldherr SM; Mohanachandran MS; Baughn TD; Nguyen KT; Sopher BL; Damian VA; Garden GA; La Spada AR
Hum Mol Genet; 2013 Mar; 22(5):890-903. PubMed ID: 23197655
[TBL] [Abstract][Full Text] [Related]
29. Altered H3 histone acetylation impairs high-fidelity DNA repair to promote cerebellar degeneration in spinocerebellar ataxia type 7.
Switonski PM; Delaney JR; Bartelt LC; Niu C; Ramos-Zapatero M; Spann NJ; Alaghatta A; Chen T; Griffin EN; Bapat J; Sopher BL; La Spada AR
Cell Rep; 2021 Nov; 37(9):110062. PubMed ID: 34852229
[TBL] [Abstract][Full Text] [Related]
30. Spinocerebellar ataxia 7 (SCA7) in Indian population: predilection of ATXN7-CAG expansion mutation in an ethnic population.
Faruq M; Srivastava AK; Singh S; Gupta R; Dada T; Garg A; Behari M; Mukerji M
Indian J Med Res; 2015 Feb; 141(2):187-98. PubMed ID: 25900954
[TBL] [Abstract][Full Text] [Related]
31. Altered p53 and NOX1 activity cause bioenergetic defects in a SCA7 polyglutamine disease model.
Ajayi A; Yu X; Wahlo-Svedin C; Tsirigotaki G; Karlström V; Ström AL
Biochim Biophys Acta; 2015; 1847(4-5):418-428. PubMed ID: 25647692
[TBL] [Abstract][Full Text] [Related]
32. Progressive degeneration in a new
Sujkowski AL; Ranxhi B; Prifti MV; Alam N; Todi SV; Tsou WL
bioRxiv; 2023 Nov; ():. PubMed ID: 37986914
[TBL] [Abstract][Full Text] [Related]
33. Lethal form of spinocerebellar ataxia type 7 with early onset in childhood.
Gousse G; Patural H; Touraine R; Chabrier S; Rolland E; Antoine JC; Perrin L
Arch Pediatr; 2018 Jan; 25(1):42-44. PubMed ID: 29248324
[TBL] [Abstract][Full Text] [Related]
34. Polyglutamine expanded Ataxin-7 induces DNA damage and alters FUS localization and function.
Niss F; Zaidi W; Hallberg E; Ström AL
Mol Cell Neurosci; 2021 Jan; 110():103584. PubMed ID: 33338633
[TBL] [Abstract][Full Text] [Related]
35. Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7.
Tan JY; Vance KW; Varela MA; Sirey T; Watson LM; Curtis HJ; Marinello M; Alves S; Steinkraus B; Cooper S; Nesterova T; Brockdorff N; Fulga T; Brice A; Sittler A; Oliver PL; Wood MJ; Ponting CP; Marques AC
Nat Struct Mol Biol; 2014 Nov; 21(11):955-961. PubMed ID: 25306109
[TBL] [Abstract][Full Text] [Related]
36. Voice Alterations in Patients With Spinocerebellar Ataxia Type 7 (SCA7): Clinical-Genetic Correlations.
Gómez-Coello A; Valadez-Jiménez VM; Cisneros B; Carrillo-Mora P; Parra-Cárdenas M; Hernández-Hernández O; Magaña JJ
J Voice; 2017 Jan; 31(1):123.e1-123.e5. PubMed ID: 26992556
[TBL] [Abstract][Full Text] [Related]
37. Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model.
Chen YC; Gatchel JR; Lewis RW; Mao CA; Grant PA; Zoghbi HY; Dent SY
Hum Mol Genet; 2012 Jan; 21(2):394-405. PubMed ID: 22002997
[TBL] [Abstract][Full Text] [Related]
38. Development of a Polymeric Pharmacological Nanocarrier System as a Potential Therapy for Spinocerebellar Ataxia Type 7.
Borbolla-Jiménez FV; García-Aguirre IA; Del Prado-Audelo ML; Hernández-Hernández O; Cisneros B; Leyva-Gómez G; Magaña JJ
Cells; 2023 Nov; 12(23):. PubMed ID: 38067163
[TBL] [Abstract][Full Text] [Related]
39. Insights into the molecular basis of polyglutamine neurodegeneration from studies of a spinocerebellar ataxia type 7 mouse model.
Grote SK; La Spada AR
Cytogenet Genome Res; 2003; 100(1-4):164-74. PubMed ID: 14526177
[TBL] [Abstract][Full Text] [Related]
40. Spinocerebellar ataxia type-7: Report of a family in Northwest Nigeria.
Alkali NH; Bwala SA; Alimi SA; Oyakhire SI
Ann Afr Med; 2016; 15(2):87-90. PubMed ID: 27044733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
